| Literature DB >> 25499642 |
Deborah E Citrin1, James B Mitchell2.
Abstract
A number of agents are used clinically to enhance the efficacy of radiotherapy today, many of which are cytotoxic chemotherapies. Agents that enhance radiation induced tumor cell killing or protect normal tissues from the deleterious effects of ionizing radiation are collectively termed radiation modifiers. A significant effort in radiobiological research is geared towards describing and testing radiation modifiers with the intent of enhancing the therapeutic effects of radiation while minimizing normal tissue toxicity. In this review, we discuss the characteristics of these agents, the testing required to translate these agents into clinical trials, and highlight some challenges in these efforts. Published by Elsevier Inc.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25499642 PMCID: PMC4270009 DOI: 10.1053/j.seminoncol.2014.09.013
Source DB: PubMed Journal: Semin Oncol ISSN: 0093-7754 Impact factor: 4.929